| Withdrawn | A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer NCT03541486 | Joseph J. Cullen, MD, FACS | Phase 2 |
| Recruiting | Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer NCT07257523 | Yonsei University | Phase 2 |
| Withdrawn | Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neopla NCT06545344 | Fred Hutchinson Cancer Center | N/A |
| Completed | Prediction Model of Pancreatic Neoplasms in CP Patients With Focal Pancreatic Lesions NCT07045181 | Changhai Hospital | — |
| Recruiting | Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula NCT06807437 | SWOG Cancer Research Network | Phase 3 |
| Recruiting | Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine NCT05687123 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | A Study of LY4170156 in Participants With Selected Advanced Solid Tumors NCT06400472 | Eli Lilly and Company | Phase 1 |
| Recruiting | A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With So NCT06051695 | A2 Biotherapeutics Inc. | Phase 1 / Phase 2 |
| Recruiting | Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals NCT06122896 | Dana-Farber Cancer Institute | EARLY_Phase 1 |
| Recruiting | Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following P NCT06411795 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Recruiting | Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ER NCT05961982 | Ohio State University Comprehensive Cancer Center | N/A |
| Recruiting | Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adeno NCT05083247 | Erasme University Hospital | Phase 2 |
| Recruiting | DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/ NCT05786716 | Cancer Research UK | Phase 2 / Phase 3 |
| Terminated | A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancrea NCT05494866 | German Cancer Research Center | Phase 1 |
| Recruiting | MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer NCT07045571 | Yingbin Liu, MD, PhD, FACS | — |
| Recruiting | Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery NCT05428358 | University of Aarhus | N/A |
| Completed | DDP ip Combined With AG in PDAC With Peritoneal Metastasis NCT05222204 | Fudan University | Phase 2 |
| Recruiting | OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. NCT04493632 | OncoSil Medical Limited | — |
| Unknown | Percutaneous Versus EUS FNAC in Pancreatic Masses NCT04623749 | Ola Kamal Mohammed Galal | N/A |
| Unknown | Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic Neoplasms NCT05259384 | Peking Union Medical College Hospital | N/A |
| Unknown | Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer NCT04718701 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Unknown | Evaluation of Difficulty Score for Robotic Pancreatoduodenectomy NCT04662346 | University of Pisa | N/A |
| Recruiting | MRE for Diagnosis of Pancreatic Masses NCT06526442 | Yu Shi | — |
| Enrolling By Invitation | Endoscopic Ultrasound Radiofrequency Ablation, Database Repository NCT04693754 | Indiana University | — |
| Unknown | Comparison of EUS-FNB Biopsy Techniques of Solid Pancreatic Lesions NCT04843956 | Hospital Universitario Dr. Jose E. Gonzalez | N/A |
| Unknown | Impact of Suction in the EUS-guided Fine Needle Biopsy of Solid Pancreatic Lesions NCT04164017 | Centro Hospitalar De São João, E.P.E. | N/A |
| Completed | EUS-FNB for Solid Pancreatic Lesions: Side-fenestrated Vs Fork-tip Needle NCT03622229 | Azienda Ospedaliera Universitaria Integrata Verona | N/A |
| Completed | Pancreatic Cancer Dietary Assessment Study NCT03616431 | The Christie NHS Foundation Trust | — |
| Completed | EUS-FNB With ROSE Vs. EUS-FNB Without ROSE NCT03322592 | Azienda Ospedaliera Universitaria Integrata Verona | N/A |
| Completed | Cancer Stem Cell Specific Aptamer's Ability to Detect Blood Circulating Cancer Stem Cells and Its Role as a Pr NCT05745415 | Yonsei University | — |
| Active Not Recruiting | Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer NCT03310632 | Golden Biotechnology Corporation | Phase 1 / Phase 2 |
| Completed | Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors o NCT03033225 | Mayo Clinic | Phase 2 |
| Unknown | The Effect of Application of TachoSil® in Pancreatoduodenectomy NCT03269955 | Asan Medical Center | Phase 4 |
| Completed | Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses NCT02910960 | AdventHealth | N/A |
| Completed | Comparing Biopsy Needles for Endoscopic Ultrasound Guided Samples for Pancreatic Masses NCT02911974 | AdventHealth | N/A |
| Completed | CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy NCT02791503 | Dr. M.R. Meijerink | N/A |
| Recruiting | Endocrine-exocrine Functions and Prognosis After Pancreatectomy NCT07396662 | National Taiwan University Hospital | — |
| Recruiting | Delayed Gastric Emptying After Pancreatic Surgery NCT07382791 | National Taiwan University Hospital | — |
| Terminated | 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients NCT02602067 | sigma-tau i.f.r. S.p.A. | Phase 1 |
| Unknown | In Vitro Models of Liver and Pancreatic Cancer NCT02436564 | Cambridge University Hospitals NHS Foundation Trust | — |
| Completed | EUS-FNA of Solid Pancreatic Mass: Comparison Between Negative Pressure and Slow-pull Technique NCT03111368 | University of Sao Paulo General Hospital | N/A |
| Terminated | Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients NCT02456051 | University of Roma La Sapienza | — |
| Completed | Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer NCT03807999 | Hacettepe University | Phase 2 |
| Completed | RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses NCT02092519 | Changi General Hospital | Phase 4 |
| Completed | Trial Comparing 19 and 25-gauge EUS-FNA Needles NCT01677312 | AdventHealth | N/A |
| Completed | The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standa NCT01996540 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | N/A |
| Completed | Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer NCT02900950 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | N/A |
| Completed | Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) NCT01420874 | Barbara Ann Karmanos Cancer Institute | Phase 1 |
| Completed | Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle NCT02181140 | Universitätsklinikum Hamburg-Eppendorf | N/A |
| Completed | 22G FNA Needle vs. 22G ProCore Needle NCT01394159 | AdventHealth | N/A |
| Completed | Prospective Study Comparing Methods of Obtainment of Specimen After EUS-FNA in Patients With Peri-pancreatic M NCT01354795 | Samsung Medical Center | N/A |
| Terminated | Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin NCT00958841 | Novartis Pharmaceuticals | Phase 2 |
| Completed | A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas NCT00711191 | Hoffmann-La Roche | Phase 1 |
| Terminated | S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regim NCT00602745 | Sanofi | Phase 3 |
| Terminated | Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancre NCT00574275 | Sanofi | Phase 3 |
| Completed | Tight Glycemic Control by Artificial Pancreas NCT00657995 | Kochi University | N/A |
| Completed | Cancer of the Pancreas Screening Study (CAPS 3) NCT00438906 | Johns Hopkins University | — |
| Completed | A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer NCT00436423 | Korea University Anam Hospital | Phase 2 |
| Completed | Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreat NCT00267020 | Eli Lilly and Company | Phase 2 |
| Completed | Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms NCT00666926 | Verastem, Inc. | Phase 1 |
| Terminated | A Study of MLN8054 in Patients With Advanced Solid Tumors NCT00249301 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Completed | Cancer Detection in Pancreatic Cysts NCT00222898 | University of Pittsburgh | — |
| Completed | Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes NCT07252570 | Centre Hospitalier Universitaire de Nice | — |
| Completed | Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 NCT00034281 | Takeda | Phase 1 |
| Completed | Prognostic Score To Predict Major Complications After Pancreaticoduodenectomy NCT01278381 | Università Vita-Salute San Raffaele | — |
| Completed | Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas NCT00005926 | National Cancer Institute (NCI) | Phase 2 |